Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Plos One|January 23, 2023
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)Raja Dhar, John Kirkpatrick, Laura Gilbert, et al.
Thorax|July 5, 2011
CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST reportJohn Kirkpatrick Field, David Baldwin, Kate Brain, et al.
Nature Communications|August 2, 2020
A distal regulatory region of a class I human histone deacetylaseNicolas D Werbeck, Vaibhav Kumar Shukla, Micha B A Kunze, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2009
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patientsPaul W Sperduto, Samuel T Chao, Penny K Sneed, et al.
Structure (London, England : 1993)|March 13, 2012
Structural dynamics associated with intermediate formation in an archetypal conformational diseaseMun Peak Nyon, Lakshmi Segu, Lisa D Cabrita, et al.
Neuro-Oncology Advances|April 28, 2023
Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastasesMichael Chan, Steven Tatter, Veronica Chiang, et al.
BMC Medicine|July 5, 2023
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE studyOlga Solovyeva, Munyaradzi Dimairo, Christopher J Weir, et al.
Journal of Neuro-Oncology|March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancerPaul W Sperduto, Norbert Kased, David Roberge, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastasesPaul W Sperduto, Norbert Kased, David Roberge, et al.
Pageof 8